Nod-like receptors in intestinal host defense: controlling pathogens, the microbiota, or both?
- PMID: 23132210
- DOI: 10.1097/MOG.0b013e32835a68ea
Nod-like receptors in intestinal host defense: controlling pathogens, the microbiota, or both?
Abstract
Purpose of review: Nod-like receptors (NLRs) are intracellular innate immune sensors of microbes and danger signals that control multiple aspects of inflammatory responses. We review the evidence that highlights the critical importance of NLRs in the host response to intestinal pathogens. Moreover, we discuss the potential roles played by NLRs in the dynamic control of the intestinal microbiota and how commensal microorganisms may affect host susceptibility to enteric bacterial pathogens through interactions with NLRs as well as with invading pathogens.
Recent findings: Recent studies targeting the intestinal microbiota in the context of NLR deficiencies suggest inherent alterations in bacterial density or abundance may underlie the development of inflammatory diseases. As commensal microorganisms may also affect host susceptibility to enteric bacterial pathogens, NLRs might promote intestinal innate immune defense through mechanisms more complex than previously anticipated.
Summary: The inclusion of the intestinal microbiota as a critical parameter in innate immunity represents an exciting new dimension for understanding NLR functioning and the clinical implications for human health.
Similar articles
-
Intracellular NOD-like receptors in host defense and disease.Immunity. 2007 Oct;27(4):549-59. doi: 10.1016/j.immuni.2007.10.002. Immunity. 2007. PMID: 17967410 Review.
-
Stories of love and hate: innate immunity and host-microbe crosstalk in the intestine.Curr Opin Gastroenterol. 2013 Mar;29(2):125-32. doi: 10.1097/MOG.0b013e32835da2c7. Curr Opin Gastroenterol. 2013. PMID: 23337934 Review.
-
Microbiota and innate immunity in intestinal inflammation and neoplasia.Curr Opin Gastroenterol. 2013 Jan;29(1):85-91. doi: 10.1097/MOG.0b013e32835a670e. Curr Opin Gastroenterol. 2013. PMID: 23207600 Review.
-
Inflammasomes in inflammatory bowel disease pathogenesis.Curr Opin Gastroenterol. 2013 Jul;29(4):363-9. doi: 10.1097/MOG.0b013e32836157a4. Curr Opin Gastroenterol. 2013. PMID: 23689522 Review.
-
The intestinal epithelial barrier: how to distinguish between the microbial flora and pathogens.Semin Immunol. 2007 Apr;19(2):106-15. doi: 10.1016/j.smim.2006.12.006. Epub 2007 Feb 26. Semin Immunol. 2007. PMID: 17324587 Review.
Cited by
-
The common prophylactic therapy for bowel surgery is ineffective for clearing Bacteroidetes, the primary inducers of systemic inflammation, and causes faster death in response to intestinal barrier damage in mice.BMJ Open Gastroenterol. 2015 Feb 6;1(1):e000009. doi: 10.1136/bmjgast-2014-000009. eCollection 2014. BMJ Open Gastroenterol. 2015. PMID: 26462264 Free PMC article.
-
Chronic inflammation and cancer: potential chemoprevention through nuclear factor kappa B and p53 mutual antagonism.J Inflamm (Lond). 2014 Aug 9;11:23. doi: 10.1186/1476-9255-11-23. eCollection 2014. J Inflamm (Lond). 2014. PMID: 25152696 Free PMC article. Review.
-
Collaborative action of Toll-like and NOD-like receptors as modulators of the inflammatory response to pathogenic bacteria.Mediators Inflamm. 2014;2014:432785. doi: 10.1155/2014/432785. Epub 2014 Dec 1. Mediators Inflamm. 2014. PMID: 25525300 Free PMC article. Review.
-
The central role of the gut microbiota in chronic inflammatory diseases.J Immunol Res. 2014;2014:689492. doi: 10.1155/2014/689492. Epub 2014 Sep 18. J Immunol Res. 2014. PMID: 25309932 Free PMC article. Review.
-
New insights into Nod-like receptors (NLRs) in liver diseases.Int J Physiol Pathophysiol Pharmacol. 2018 Mar 10;10(1):1-16. eCollection 2018. Int J Physiol Pathophysiol Pharmacol. 2018. PMID: 29593846 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials